SPD602-203 (formerly FBS0701-CTP-16), titled Phase 2, 24 week, Randomized, Open Label, Multi-Center Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two SSP004184 (SPD602) Doses in the...

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/136/30/16

Funding

  • Shire Development LLC (SPD602-203)